search
Back to results

Innovative Biotechnological Production of Antioxidant Products (Antiox-Plus)

Primary Purpose

Oxidative Stress, Inflammation, Body Weight

Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Hydroxytyrosol/Essential oils
Sponsored by
University of Ioannina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Oxidative Stress

Eligibility Criteria

25 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: age between 25 and 65 years the absence of any chronic health conditions adequate understanding of the study Exclusion Criteria: the presence of any chronic health conditions (diabetes, hypertension, dyslipidemia) intake of nutritional supplements over the past 60 days heavy smokers (≥25 cigarettes/day) high alcohol use (men >14 drinks/week, women >7 drinks/week)

Sites / Locations

  • University of Ioannina

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Supplement

Arm Description

The supplement capsules were given to 12 healthy subjects, aged 26-52, once a day for 8 weeks

Outcomes

Primary Outcome Measures

Homocysteine
Homocysteine (μmol/L)
Fasting blood glucose
Fasting blood glucose (md/dL)
oxLDL
oxLDL (mU/mL)

Secondary Outcome Measures

LDL-cholesterol
LDL-cholesterol (mg/dL)
HDL-cholesterol
HDL-cholesterol (mg/dL)
Glutathione
Glutathione (mU/mL)
Catalase
Catalase (units/mL)

Full Information

First Posted
November 30, 2022
Last Updated
January 9, 2023
Sponsor
University of Ioannina
search

1. Study Identification

Unique Protocol Identification Number
NCT05679310
Brief Title
Innovative Biotechnological Production of Antioxidant Products
Acronym
Antiox-Plus
Official Title
Innovative Biotechnological Production of Antioxidant Products of Plant Origin From Microbial Factories, and Essential Oils From the Greek Flora, for the Creation of New Quality Health Products and Nutritional Supplements
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
February 10, 2022 (Actual)
Primary Completion Date
July 6, 2022 (Actual)
Study Completion Date
September 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Ioannina

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Several natural compounds have been explored as immune-boosting, antioxidant, and anti-inflammatory dietary supplements. Amongst them, hydroxytyrosol a natural antioxidant found in olive products, and endemic medicinal plants have attracted the scientific's community and industry's interest. The safety and biological activity of a standardised supplement containing 10 mg of hydroxytyrosol synthesized using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from oregano vulgaris, sage officinalis and crithmum maritimum in an open-label, single-arm, prospective clinical study were studied. The supplement capsules were given to 12 healthy subjects, aged 26-52, once a day for 8 weeks.
Detailed Description
The study was designed to evaluate the safety and biological activity of the supplement Antiox-Plus: one capsule/day, 15 minutes before their main meal which contained 10 mg of HT, synthesised using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from Origanum vulgare, Sage officinalis and Crithmum maritimum. The volunteers will consume the supplement for 8 weeks. A follow-up analysis will be performed one month after the end of the supplementation period (12 weeks from the initiation of the study). During this time, the participants will consume a placebo. The volunteers are instructed to maintain their normal dietary habits. The following measurements will be taken: A) Dietary assessment at the beginning of the study (week 0), B) Body composition analysis at the beginning (week 0) and the end of the study (week 8), C) biochemical and laboratory analysis of plasma samples at week 0, 8 and 12. The volunteers will record their food intake for 3 days (including one day of the weekend) and will fulfil a food frequency questionnaire. Analysis of their data will be done by a certified nutritionist. Nutritional assessment will be performed using the Evexis dietary software. The Tanita Dual Frequency Body Composition Monitor "Innerscan" will be employed to measure weight, muscle mass, muscle quality score, heart rate, body fat (%), physique rating, visceral fat, metabolic age, basal metabolic rate, bone mass, body water (%) and body mass index (BMI) in the morning. Physical activity will be assessed by the Greek version of the short International Physical Activity Questionnaire (IPAQ-short).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oxidative Stress, Inflammation, Body Weight, Homocystine; Metabolic Disorder

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Supplement
Arm Type
Experimental
Arm Description
The supplement capsules were given to 12 healthy subjects, aged 26-52, once a day for 8 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Hydroxytyrosol/Essential oils
Intervention Description
A dietary supplement containing 10 mg of hydroxytyrosol, synthesised using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from oregano vulgaris, sage officinalis and crithmum maritimum.
Primary Outcome Measure Information:
Title
Homocysteine
Description
Homocysteine (μmol/L)
Time Frame
Change from Baseline up to 12 weeks
Title
Fasting blood glucose
Description
Fasting blood glucose (md/dL)
Time Frame
Change from Baseline up to 12 weeks
Title
oxLDL
Description
oxLDL (mU/mL)
Time Frame
Change from Baseline up to 12 weeks
Secondary Outcome Measure Information:
Title
LDL-cholesterol
Description
LDL-cholesterol (mg/dL)
Time Frame
Change from Baseline up to 12 weeks
Title
HDL-cholesterol
Description
HDL-cholesterol (mg/dL)
Time Frame
Change from Baseline up to 12 weeks
Title
Glutathione
Description
Glutathione (mU/mL)
Time Frame
Change from Baseline up to 12 weeks
Title
Catalase
Description
Catalase (units/mL)
Time Frame
Change from Baseline up to 12 weeks
Other Pre-specified Outcome Measures:
Title
Total Antioxidant Capacity
Description
Total Antioxidant Capacity (mM a-tocopherol)
Time Frame
Change from Baseline up to 12 weeks
Title
Malonaldehyde
Description
Malonaldehyde (μΜ)
Time Frame
Change from Baseline up to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age between 25 and 65 years the absence of any chronic health conditions adequate understanding of the study Exclusion Criteria: the presence of any chronic health conditions (diabetes, hypertension, dyslipidemia) intake of nutritional supplements over the past 60 days heavy smokers (≥25 cigarettes/day) high alcohol use (men >14 drinks/week, women >7 drinks/week)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patra Vezyraki, PhD
Organizational Affiliation
University of Ioannina, School of Health Sciences, Department of Medicine, Laboratory of Physiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ioannina
City
Ioannina
State/Province
Epirus
ZIP/Postal Code
45110
Country
Greece

12. IPD Sharing Statement

Learn more about this trial

Innovative Biotechnological Production of Antioxidant Products

We'll reach out to this number within 24 hrs